Blood thinner for children getting a central line
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether giving a blood thinner before placing a central line (a special IV) helps prevent clots in critically ill children. It could lower the risk of problems from the line.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is in the hospital and needs a new central line for their care.
- Your child does not have a known bleeding disorder or very low platelets (under 50,000).
- Your child is not already on blood thinners for another reason.
- Your child does not have a heparin allergy or a history of a low-platelet reaction to heparin.
- The line being placed is a standard central line or PICC, not a dialysis catheter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
This trial tests whether a daily injection of a blood-thinning medicine called enoxaparin (Lovenox) can safely prevent dangerous blood clots in teens who are critically ill in the intensive care unit with an IV line and an infection or inflammation. It may help reduce the risk of blood clots without causing excess bleeding.
This study looks at how a common blood thinner (enoxaparin) is processed in the body of ICU patients with kidney failure, including those on dialysis. The goal is to make sure the dose is safe and effective for preventing blood clots in this fragile group.
This study compares two doses of a blood thinner (enoxaparin) to see which better prevents blood clots in patients with severe injuries who are in the intensive care unit. It helps doctors choose the best dose to keep you safe and healthy.
This study tests two experimental drugs, REGN7508 and REGN9933, to see if they can safely prevent blood clots in the arm or chest in people who need a PICC line. If you are getting a PICC for treatments like chemotherapy or antibiotics, you may be able to join.
This trial tests if using a push-pull method to collect blood from a central line (a special IV) causes less red blood cell damage and blood loss in hospitalized children compared to the standard method.
Hear when a new Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.